Publications by authors named "Christopher Tankersley"

Claim this Profile
A
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings.
Steven P Treon, Camille N Kotton, David J Park, Giorgia Moranzoni, Camilla K Lemvigh, Christopher Tankersley

Front Immunolยท February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis